GSK Plc Company Top Insiders
GLAXF Stock | USD 16.87 0.17 1.00% |
GSK Plc employs about 45 people. The company is managed by 10 executives with a total tenure of roughly 34 years, averaging almost 3.0 years of service per executive, having 4.5 employees per reported executive. Examination of GSK Plc's management performance can provide insight into the company performance.
Emma Walmsley President President - Consumer Healthcare Worldwide |
James Ford President Senior Vice President General Counsel |
GSK |
GSK Plc Management Team Effectiveness
The company has return on total asset (ROA) of 0.0659 % which means that it generated a profit of $0.0659 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3131 %, meaning that it generated $0.3131 on every $100 dollars invested by stockholders. GSK Plc's management efficiency ratios could be used to measure how well GSK Plc manages its routine affairs as well as how well it operates its assets and liabilities.GSK Plc Workforce Comparison
GSK plc is rated below average in number of employees category among its peers. The total workforce of Drug Manufacturers—General industry is currently estimated at about 1 Million. GSK Plc adds roughly 45.0 in number of employees claiming only tiny portion of equities under Drug Manufacturers—General industry.
The company has Profit Margin (PM) of 0.51 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.25 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.25. GSK plc Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. GSK plc Price Series Summation is a cross summation of GSK Plc price series and its benchmark/peer.
GSK Plc Notable Stakeholders
A GSK Plc stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as GSK Plc often face trade-offs trying to please all of them. GSK Plc's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting GSK Plc's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Emma Walmsley | President - Consumer Healthcare Worldwide | Profile | |
James Ford | Senior Vice President General Counsel | Profile | |
Iain Mackay | CFO - Designate, Executive Director | Profile | |
David Redfern | Chief Strategy Officer | Profile | |
Diana Conrad | Chief Officer | Profile | |
Sally Jackson | VP Office | Profile | |
Shobie Ramakrishnan | Chief Officer | Profile | |
Sarah EltonFarr | Head Relations | Profile | |
Julie Brown | Chief Officer | Profile | |
Tony Wood | Chief Officer | Profile |
About GSK Plc Management Performance
The success or failure of an entity such as GSK plc often depends on how effective the management is. GSK Plc management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of GSK management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the GSK management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. Glaxosmithkline Plc is traded on OTC Exchange in the United States.
GSK Plc Workforce Analysis
Traditionally, organizations such as GSK Plc use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare GSK Plc within its industry.GSK Plc Manpower Efficiency
Return on GSK Plc Manpower
Revenue Per Employee | 651.6M | |
Revenue Per Executive | 2.9B | |
Net Income Per Employee | 332.4M | |
Net Income Per Executive | 1.5B |
Complementary Tools for GSK Pink Sheet analysis
When running GSK Plc's price analysis, check to measure GSK Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GSK Plc is operating at the current time. Most of GSK Plc's value examination focuses on studying past and present price action to predict the probability of GSK Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GSK Plc's price. Additionally, you may evaluate how the addition of GSK Plc to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |